In addition, in contrast with previous findings, a systematic review and metanalysis by Overbeek et al. (2018), showed that it is not possible to conclude whether DPP-4 inhibitors were associated with an increased risk of site-specific cancer including TC. Here, DPP4 is linked to cancer.